MassBiologics receives orphan drug status from FDA for hepatitis C treatment Medical Xpress Complications from chronic HCV infection are the most common indications for liver transplantation today. For patients with end-stage liver disease or hepatocellular carcinoma resulting from HCV infection, liver transplantation is often the only ... |
